# Filing Detail

Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001213900-24-099217
Filing Date
2024-11-15
Accepted
2024-11-15 17:21:12
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PROXY STATEMENT | ea0214566-05.htm | DEFR14A | 828373
2 | GRAPHIC | tcampaign_logo.jpg | GRAPHIC | 51913
3 | GRAPHIC | tproxy_001.jpg | GRAPHIC | 1309425
4 | GRAPHIC | tproxy_002.jpg | GRAPHIC | 1025722
| Complete submission text file | 0001213900-24-099217.txt |  | 4118159

Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

EIN.: 462137136 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-41512 | Film No.: 241468953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)